Client story
Bayer uses AI to unleash the potential of preclinical data
Registration Full
Advancing Drug Development through AI & ML - Registration Closed
Thank you for your interest! The roundtable is now at capacity, and we are no longer accepting new registrations. However, you can sign up to receive a summary of the event’s insights.
The event will feature an engaging discussion on how artificial intelligence and machine learning are transforming drug development, with a focus on San Diego’s thriving life sciences ecosystem. Industry leaders will explore key topics, including advancements in drug discovery, development, and deployment/marketing. Attendees will gain valuable insights into the future of AI and ML within the biopharmaceutical industry.
Sign up to receive the summary and stay informed about the latest innovations in drug development!
Event Details:
Date: Wednesday, October 30, 2024
Time: 4:30 PM - 6:30 PM
Location: 9925 Pacific Heights Boulevard, San Diego, CA 92121
Speakers
Prasanna Pendse (Host)
Global Director of AI Strategy at Thoughtworks
James Gillespie (Host)
PhD, Senior Advisor in Healthcare & Life Sciences at Thoughtworks and a Senior Advisor at Stanford University
Aiden Aceves
PhD, Board Member, Cirsium Biosciences. Board Observer at ArrePath, Basking Biosciences, Capacity Bio, DEM Biopharma, ImmuneBridge, Profluent Bio, Superluminal Medicines, and Switch Therapeutic
David-Alexandre Gros
MD, MBA, Chief Executive Officer & Board Director, Eledon Pharmaceuticals
George Ng
JD, CEO & Board Director, Processa Pharmaceuticals | Board Member, TuHURA Biosciences | Board Member & Co-Founder, IACTA Pharmaceuticals | Partner, PENG Life Science Ventures
Louis Metzger
PhD, Co-Founder and CEO, Stealth Targeted Radiotherapeutics NewCo
Magda Marquet
PhD, Co-Founder and Co-CEO, ALMA Life Sciences | Chairman of the Board, MatriSys Bioscience, Inc. | Board Member at Arcturus Therapeutics, AnaptysBio, Epitracker, Alume Biosciences, HUYA Bioscience International, SENTÉ®
Randy Berholtz
JD, MBA, M.Litt, Co-Founder, VP, & General Counsel, Orbit Genomics | Partner, Ventac Partners | Board Member, Eysz | Co-Founder & Chairman of the Board, RORA Biologics | Co-Founder & Chairman of the Board, Ambulero
Sheila Gujrathi
MD, Executive Chair of the Board of Directors, Ventyx Biosciences | Chair of the Board of Directors, IMMPACT BIO | Board of Directors, Janux Therapeutics | Chair of the Board of Directors, ADARx Pharmaceuticals
Weian Zhao
PhD, Founder & CEO, Aureka Biotechnologies | Full Tenure Professor, UC Irvine | Co-Founder, Amberstone Biosciences
